Funder
National Natural Science Foundation of China
Government of Jiangsu Province
Jiangsu University
Natural Science Foundation of Jiangsu Province
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Zhang H, Lu B. microRNAs as biomarkers of ovarian cancer. Expert Rev Anticancer Ther. 2020;20:373–85.
2. Dion L, Carton I, Jaillard S, Nyangoh Timoh K, Henno S, Sardain H, et al. The landscape and therapeutic implications of molecular profiles in epithelial ovarian cancer. J Clin Med. 2020;9:2239.
3. Liu L, Liu P, Liang Z, Li R, Shen M, Xu H, et al. Poly (ADP-ribose) polymerase inhibitors combined with other small-molecular compounds for the treatment of ovarian cancer. Anticancer Drugs. 2019;30:554–61.
4. Lee A. Fuzuloparib: first approval. Drugs. 2021;81:1221–6.
5. Yamashita T. [Treatment of delusions of parasitosis: efficacy of transcutaneous electrical stimulation]. Seishin Shinkeigaku Zasshi. 1986;88:1–13.